Market Cap 3.47B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 10,696,199
Avg Vol 8,164,194
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 51%
Beta 1.20
Analysts Strong Sell
Price Target $16.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Rastafari
Rastafari Aug. 26 at 1:38 AM
$ABCL well done my fellow longs! This stock will eventually be triple digits (one day)!
0 · Reply
Spicy_Trade
Spicy_Trade Aug. 26 at 12:33 AM
AbCellera Biologics Inc. ( $ABCL ) SpicyTrade - Daily Stock Analysis https://youtu.be/GbmTZlipEbY?si=pCXOB_6OL5SBDbRA
0 · Reply
Samb2344
Samb2344 Aug. 25 at 11:04 PM
$ABCL $13S is coming
0 · Reply
knomoney
knomoney Aug. 25 at 10:12 PM
$ABCL Well shit. Thought it would get a bit cheaper. Guess I’m averaging up
0 · Reply
Shaffin786
Shaffin786 Aug. 25 at 9:42 PM
$ABCL $RXRX $SPY $TWST $XBI For RXRX specifically, I like this development. It strengthens the long-term narrative that AI-driven drug development is moving from being considered experimental technology toward something regulators are explicitly building infrastructure around. And the second proposed deputy commissioner dedicated to drugs could become even more important for RXRX if it ultimately leads to more predictable, efficient clinical-development and approval pathways.
0 · Reply
Robby83
Robby83 Aug. 25 at 8:49 PM
$ABCL well I missed this one... It's always nice to get a spam tag during consolidation, I'm not much for chasing. Had the same setup as $GANX, oscillating accumulation, followed by ascending triangles leading to a breakout... Beautiful chart action on AbCellera.
0 · Reply
Jwa68
Jwa68 Aug. 25 at 8:47 PM
$ABCL $GANX $COYA COYA did a webinar exactly on this a few months ago with NFL former player moderator and Leigh Steinberg and the COYA medical experts. 1 in 4 pro football players! Just incredible. Main stream media picked up the journal article, don't see that often. Not ALS but we know ALS also significantly higher. Study’s Alarming Finding: At Least 1 in 4 N.F.L. Players Gets Brain Disease https://www.nytimes.com/2026/08/25/us/nfl-cte-brain-disease.html?smid=nytcore-ios-share
0 · Reply
topstockalerts
topstockalerts Aug. 25 at 8:40 PM
$ABCL a lot to like about this action
0 · Reply
DeMampCamp
DeMampCamp Aug. 25 at 8:40 PM
$ABCL What an incredible turnaround this has been over the past month or so! ABCL longs can finally smile and feel proud of their investment here. We all know it took a lot longer than we originally expected, but that patience is finally being rewarded. Cheers to management, the longtime holders who stuck with it, and even the short-term traders who have helped get us to where we are today. It’s been quite a ride and hopefully, we’re just getting started. Cheers to ABCL and what looks like a very bright future ahead! 🍻
1 · Reply
Norap58
Norap58 Aug. 25 at 8:37 PM
$ABCL I don’t care how rich you are no one drops over 550/k on something that moved up 77% in just over a month if they aren’t dead serious about their intentions.
1 · Reply
Latest News on ABCL
AbCellera rises 17.0%

2026-08-25T16:06:05.000Z - 9 hours ago

AbCellera rises 17.0%


AbCellera rises 10.7%

2026-08-25T14:06:36.000Z - 11 hours ago

AbCellera rises 10.7%


AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 14 days ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 14 days ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 15 days ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 15 days ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 15 days ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 15 days ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 19 days ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 20 days ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 20 days ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 20 days ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 20 days ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 20 days ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 7 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 7 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 7 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


Rastafari
Rastafari Aug. 26 at 1:38 AM
$ABCL well done my fellow longs! This stock will eventually be triple digits (one day)!
0 · Reply
Spicy_Trade
Spicy_Trade Aug. 26 at 12:33 AM
AbCellera Biologics Inc. ( $ABCL ) SpicyTrade - Daily Stock Analysis https://youtu.be/GbmTZlipEbY?si=pCXOB_6OL5SBDbRA
0 · Reply
Samb2344
Samb2344 Aug. 25 at 11:04 PM
$ABCL $13S is coming
0 · Reply
knomoney
knomoney Aug. 25 at 10:12 PM
$ABCL Well shit. Thought it would get a bit cheaper. Guess I’m averaging up
0 · Reply
Shaffin786
Shaffin786 Aug. 25 at 9:42 PM
$ABCL $RXRX $SPY $TWST $XBI For RXRX specifically, I like this development. It strengthens the long-term narrative that AI-driven drug development is moving from being considered experimental technology toward something regulators are explicitly building infrastructure around. And the second proposed deputy commissioner dedicated to drugs could become even more important for RXRX if it ultimately leads to more predictable, efficient clinical-development and approval pathways.
0 · Reply
Robby83
Robby83 Aug. 25 at 8:49 PM
$ABCL well I missed this one... It's always nice to get a spam tag during consolidation, I'm not much for chasing. Had the same setup as $GANX, oscillating accumulation, followed by ascending triangles leading to a breakout... Beautiful chart action on AbCellera.
0 · Reply
Jwa68
Jwa68 Aug. 25 at 8:47 PM
$ABCL $GANX $COYA COYA did a webinar exactly on this a few months ago with NFL former player moderator and Leigh Steinberg and the COYA medical experts. 1 in 4 pro football players! Just incredible. Main stream media picked up the journal article, don't see that often. Not ALS but we know ALS also significantly higher. Study’s Alarming Finding: At Least 1 in 4 N.F.L. Players Gets Brain Disease https://www.nytimes.com/2026/08/25/us/nfl-cte-brain-disease.html?smid=nytcore-ios-share
0 · Reply
topstockalerts
topstockalerts Aug. 25 at 8:40 PM
$ABCL a lot to like about this action
0 · Reply
DeMampCamp
DeMampCamp Aug. 25 at 8:40 PM
$ABCL What an incredible turnaround this has been over the past month or so! ABCL longs can finally smile and feel proud of their investment here. We all know it took a lot longer than we originally expected, but that patience is finally being rewarded. Cheers to management, the longtime holders who stuck with it, and even the short-term traders who have helped get us to where we are today. It’s been quite a ride and hopefully, we’re just getting started. Cheers to ABCL and what looks like a very bright future ahead! 🍻
1 · Reply
Norap58
Norap58 Aug. 25 at 8:37 PM
$ABCL I don’t care how rich you are no one drops over 550/k on something that moved up 77% in just over a month if they aren’t dead serious about their intentions.
1 · Reply
Norap58
Norap58 Aug. 25 at 8:33 PM
$ABCL Sorry, meant 10.64 purchase.
1 · Reply
Norap58
Norap58 Aug. 25 at 8:32 PM
$ABCL Insiders don’t buy 53/k shares at 20.64 after an almost double in the value of the stock to clip a few points on the upside. Does not happen This thing was under 6 in July.
0 · Reply
ITF
ITF Aug. 25 at 7:54 PM
$ABCL a retest 2maro of 12.15 and with high volume we are going to 15.48 in a few days, conviction is without any faults - insider buying - technical analysis shows a bull raging
1 · Reply
Merlintrader
Merlintrader Aug. 25 at 7:12 PM
$ABCL ABCL635 produced an 83 per cent reduction in moderate-to-severe hot-flash frequency at week 4 against 33 per cent on placebo, with no serious adverse events and no liver signal reported. One day later AbCellera launched a primary offering, priced on August 12 at 9.75 dollars: 17,435,897 common shares plus pre-funded warrants for a further 3,076,926, gross proceeds 200.0 million dollars, delivered August 14. That is 20,512,823 new share equivalents against 306,469,632 shares outstanding at June 30, roughly 6.7 per cent. Cash and securities were 540.1 million dollars at June 30, and the company counts more than 675 million of available liquidity including about 110 million of government funding capacity. Free to read, no subscription. Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/abcellera-biologics-stock-hub/?utm_source=stocktwits&utm_medium=social&utm_campaign=abcl-hub-25ago2026
0 · Reply
Ckkung71
Ckkung71 Aug. 25 at 7:06 PM
$ABCL Insider can sell of many resons but they only buy of one 💰 Hold on you stock it’s going up this autumn.
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 7:04 PM
$ABCL POWER HOUR $13’sss
0 · Reply
Odoji
Odoji Aug. 25 at 7:04 PM
$ABCL 💉
0 · Reply
BioRich
BioRich Aug. 25 at 7:02 PM
$OTLK $RGNX $MPLT $CAPR. Nice to see 4 of my Top 5 winners being what I called distressed (or disconnect) stocks. Damaged, but not done. The other in the Top 5, $ABCL, is not distressed. In fact, it's a foundational portfolio lock. $OTLK - Most challenged. Approval, relative silence, awaiting direction. Good entry point, but low expectations. Fits more into the flipper zone right now rather than a conviction play. $RGNX - Recent market overreaction caused this to drop ~25%. That freed up cheap shares. Overall pipeline and cash in tact, RGNX-201 has the potential to be a catalyst pop if/when clinical hold removed. $MPLT - Another massive overreaction where the thesis remained intact. Had been lulling us to sleep, but it's starting to wake up a bit. Worth a watch or strong starter position. $CAPR - The holy grail here. Recent developments position them to what I believe is a favorable FDA decision later this year. SP is massively depressed and could be a blind buy until $11.
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Aug. 25 at 6:53 PM
$ABCL WE ARE GOING TO $26
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 6:53 PM
$ABCL WOW!! The BUY ORDERs coming in on LEVEL II. I bet it’s CARL buying more or more management.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Aug. 25 at 6:51 PM
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 25 at 6:50 PM
$ABCL HERE WE GO!!! Last Chance BUY ALL YOU can see you at $13’sss
0 · Reply